About
Mitochondrial modulators
Areas of Focus
Categories
Small Molecule PharmaceuticalNJ, NY, PA
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
5
As Collaborator
0
Total Enrollment
378
By Phase
PHASE1: 5
By Status
UNKNOWN: 2COMPLETED: 2ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT05212987Lead Sponsor
Study of FCN-098 in Patients With Advanced Solid Tumor
PHASE1Unknown
43 participants
Started: Dec 31, 2021 · Completed: Oct 12, 2024
NCT04682808Lead Sponsor
A Study of FCN-338 in Patients With Chronic CLL/SLL
PHASE1Active, not recruiting
99 participants
Started: May 13, 2021 · Completed: Dec 31, 2024
NCT04687423Lead Sponsor
Study of FCN-011 in Patients With Advanced Solid Tumor（Phase I）and NTRK Fusion Positive Advanced Solid Tumor （Phase II）
PHASE1Unknown
82 participants
Started: Apr 13, 2021 · Completed: Mar 31, 2024
NCT04622124Lead Sponsor
A Safety and Tolerability Study of FCN-207 in Healthy Volunteers
PHASE1Completed
132 participants
Started: Nov 11, 2020 · Completed: Jun 7, 2022
NCT03951116Lead Sponsor
Study of FCN-437c in Patients With Advanced Solid Tumors
PHASE1Completed
22 participants
Started: Jun 25, 2019 · Completed: Dec 8, 2021
Locations (1)
Headquarters
Blue Bell, PA, United States
Map
Loading map...